Pfizer’s Xeljanz follow-up abrocitinib gathers momentum

ImaginAb joins with AZ, Pfizer and Takeda to develop tumour ...

LA-based biotech ImaginAb has signed a multi-party agreement with pharma giants AstraZeneca, Pfizer, and Takeda, for technology that allows scientists to see inside tumours, and monitor whe

Pfizer inks deal with Ionis and Akcea for potential blockbus...

Pfizer has signed a deal with Ionis’ affiliate Akcea Therapeutics, to develop a potential blockbuster antisense therapy to treat patients with certain cardiovascular and metabolic diseases

FDA approves J&J's prostate cancer drug Erleada in new use, ...

The FDA has approved Johnson & Johnson’s prostate cancer drug Erleada (apalutamide) for patients whose prostate cancer has spread.

Keytruda combo cleared as first-line kidney cancer treatment...

The top pharma companies by revenue 2018